Participating Institutions – Map

North America

Children’s Hospital Los Angeles
Los Angeles, California, United States of America

Children’s Hospital of Philadelphia
Philadelphia, Pennsylvania, United States of America

Columbia University Medical Center
New York, New York, United States of America

Duke University Medical Center
Durham, North Carolina, United States of America

Dana-Farber Cancer Institute
Boston, Massachusetts, United States of America

The Louisiana State University Health
Sciences Center
New Orleans, Louisiana, United States of America

Memorial Sloan Kettering Cancer Center
New York, New York, United States of America

Providence Cancer Institute
Portland, Oregon, United States of America

Sidney Kimmel Cancer Center at Johns
Hopkins University; Allegheny Health
Network, Affiliate
Baltimore, Maryland, United States of America

The University of California, San Francisco –
Helen Diller Family Comprehensive Cancer
Center
San Francisco, California, United States of America

The University of Chicago
Chicago, Illinois, United States of America

University Health Network – Princess
Margaret Cancer Centre
Toronto, Ontario, Canada

University of Miami – Sylvester
Comprehensive Cancer Center
Miami, Florida, United States of America

Vanderbilt University Medical Center /
Ingram Cancer Center
Nashville, Tennessee, United States of America

Wake Forest University Health Sciences
Winston-Salem, North Carolina, United States of America

Yale University
New Haven, Connecticut, United States of America

Europe

Institut Gustave Roussy
Paris, France

The Netherlands Cancer Institute,
Amsterdam, on behalf of the Center for
Personalized Cancer Treatment
Utrecht, Netherlands

Vall d’Hebron Institute of Oncology
Barcelona, Spain

Asia

Korea University Anam Hospital
Seoul, Korea

Participating Institution Requirements

  • Provide 500 genomic records to start (Data must be CLIA- or ISO-certified)
  • Provide 500 genomic records each subsequent year of participation (Data must be CLIA- or ISO-certified)
  • Limited Data sets as defined by 45 C.F.R. § 164.514(e) will be provided
  • If de-identified datasets are provided, the process must adhere to the project’s established protocols
  • Maintain IRB approval
  • Meet data standards and deadlines
  • Participate in meetings
  • Participate in committees and subcommittees
  • Execute the Main Participation Agreement and agree to all exhibits, including the Data User Agreement